MAYO CLINIC
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma
Phase 2
Completed
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- First Posted Date
- 2008-02-15
- Last Posted Date
- 2011-05-16
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 15
- Registration Number
- NCT00616720
Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2013-12-18
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 927
- Registration Number
- NCT00613470
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
Studying the Effect of Freeze-Dried Table Grape Powder on Blood Estrogen Levels in Postmenopausal Women
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2008-02-08
- Last Posted Date
- 2019-04-08
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT00611104
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Phase 2
Completed
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- First Posted Date
- 2008-02-06
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 63
- Registration Number
- NCT00609167
- Locations
- ๐บ๐ธ
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
๐จ๐ฆPrincess Margaret Hospital, Toronto, Ontario, Canada
Percutaneous Cryoablation in Treating Patients With Painful Bone Metastases
Not Applicable
Completed
- Conditions
- Metastatic CancerUnspecified Adult Solid Tumor, Protocol SpecificPain
- First Posted Date
- 2008-02-06
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 60
- Registration Number
- NCT00608855
- Locations
- ๐บ๐ธ
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
๐บ๐ธMayo Clinic - Jacksonville, Jacksonville, Florida, United States
๐บ๐ธNYU Cancer Institute at New York University Medical Center, New York, New York, United States
Study Comparing Two Types of Ports in Patients With Cancer Receiving Intravenous Chemotherapy
Phase 2
Completed
- Conditions
- Vascular Access Device ComplicationsUnspecified Adult Solid Tumor, Protocol Specific
- Interventions
- Procedure: vascular access device placement
- First Posted Date
- 2008-02-06
- Last Posted Date
- 2014-05-09
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 100
- Registration Number
- NCT00607880
- Locations
- ๐บ๐ธ
Mayo Clinic - Jacksonville, Jacksonville, Florida, United States
Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase 2
Completed
- Conditions
- LeukemiaLymphoma
- Interventions
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2020-01-27
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 45
- Registration Number
- NCT00602836
- Locations
- ๐บ๐ธ
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
๐บ๐ธMayo Clinic Cancer Center, Rochester, Minnesota, United States
๐บ๐ธMayo Clinic - Jacksonville, Jacksonville, Florida, United States
Radiation Therapy in Treating Women Undergoing Lumpectomy for Stage I or Stage IIA Breast Cancer
Phase 2
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2011-08-10
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 50
- Registration Number
- NCT00602108
Vandetanib and Temozolomide in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery
Phase 1
Withdrawn
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2014-03-10
- Lead Sponsor
- Mayo Clinic
- Registration Number
- NCT00601614
ABT-510 in Treating Patients With Metastatic Melanoma
Phase 2
Completed
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2011-05-16
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 42
- Registration Number
- NCT00602199
ยฉ Copyright 2025. All Rights Reserved by MedPath